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The Editorial on the Research Topic
The Human Gutome: Nutrigenomics of Host-Microbiome Interactions
The concept of the “Human Gutome,” as a unifying term for multilevel system interaction between
the microbiome and the human digestive tract, was established in 2011 (Dimitrov, 2011). In the
effort to overcome low translatability of bench-to-bedside research, two major approaches gained
recent attention, namely the computational modeling of human metabolism (Aurich and Thiele,
2016) and organ-on-chip, including gut-on-chip tools (Shah et al., 2016). Human digestion starts
in the mouth and the correlation between oral microbial species and health is well established
(Lockhart et al., 2012). Previously, we also suggested a practical model of cross-talk among diet, oral
microbial pathogens and disease susceptibility (Dimitrov). Precision nutrition takes into account
nutritional epidemiology across different ethnic groups, differences in macro and micro nutrient
intake during lifespan, snapshot or longitudinal multi-omics profiles with or without nutritional
challenges in different phenotypes, as well as personalized tailor-made and/or algorithm-based
diets targeting individual nutritional requirements for disease prevention or in conjunction with
dedicated dietary recommendations with or without pharmacotherapy (Ferguson et al., 2016). The
papers in this issue present inter-disciplinary approaches of research of system biology (Shoaie and
Nielsen) and medical practice (Salazar et al.). They look at the dynamic systems of the human
body as part of an integrated whole (Magnúsdóttir et al.). Models on extensive experimental data
are applied (Adamberg et al.; Ahmed Nasef et al.), and aim to understand disease mechanism and
suggest personalized treatments (Tailford et al.).
The “Cross Talks” concept gained recent popularity especially among metabolic diseases
researchers. In particular, stepwise, the concept evolved from adipose—muscle to gut-brain-
adipose-muscle (Argilés et al., 2005; Bartness et al., 2005; Cegla et al., 2010). Quite the same
principle, at present, can be postulated for the human microbiome and gut physiology. Tellez et al.
present an excellent example for gathering of several medical subjects: intestinal permeability—
mucosal viscosity—gut microbiome. Special value of the cited research is the addition of bone
mineral density—a topic that is not often mentioned within the booming microbiome science.
Mathematical modeling as a powerful tool for the organization and analysis of microbiome
biological data is reviewed in detail by Shoaie and Nielsen. The current challenge to interrelate
different levels of information, from the genome to the transcriptome, the proteome and the
metabolome, and experimental data fromwidely used high-throughput techniques is described as a
practical didactical guide of how to recreate a given phenotype, and ultimately to make predictions
about network and cellular behavior. A real-life modeling example can be visualized from the
paper of Magnúsdóttir et al., where readers from different disciplines, from bioinformaticians to
clinicians, are provided with hands-on practical tutorial of computational predictions of how the
microbiota contribute to the B-vitamin pool of the gut, and how the humanmetabolism can benefit
from the B-vitamin biosynthesis of the microbiota.
The myriad of clinical changes, including a basal pro-inflammatory state (inflamm-aging),
that directly interfaces with the microbiota of older adults and enhances susceptibility to
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disease accompanying aging is reviewed by Salazar et al. Studies
in older adults demonstrate that the gut microbiota correlates
with diet and basal level of inflammation. Links exist between
the microbiota and a variety of clinical problems plaguing
older adults, including physical frailty, Clostridium difficile colitis
and atherosclerotic metabolic syndrome. Manipulation of the
microbiota and microbiome of older adults holds promise
as an innovative strategy to influence the development of
comorbidities associated with aging.
The starch utilization system from B. thetaiotaomicron has
been studied in detail and the way the composition of amino acids
affects fructan utilization by B. thetaiotaomicron and alters the
profile of produced SCFAs in a defined medium is described by
Adamberg et al. Their results show that fructan metabolism of B.
thetaiotaomicron DSM 2079 depends on the amino acid supply.
B. thetaiotaomicron is one of the most versatile glycan utilizers
in the intestine. Even though the majority of intestinal micro-
organisms prefer glycans over proteins as growth substrates,
proteins are also utilized, in particular in the distal colon where
the availability of carbohydrates is limited because they have been
used up in the proximal part of the intestinal tract. In this paper
the amino acids metabolized most actively by B. thetaiotaomicron
were Asp, Ser, and Thr.
Strategies used by mucin-degrading bacteria to utilize host
glycans are reviewed by Tailford et al., where readers can navigate
through the 20 genes encoding mucins, how those genes express
peripheral terminal epitopes for glycan diversity, how different
bacterial strains interact via different enzymes to influence cyalic
acid, fucose and blood group metabolism. Special attention is
paid to the role of mucin-degrading bacteria in modulating
the gut inflammatory response at obese and diabetic states.
The bacterium Akkermansia muciniphila is more common in
healthy-weight humans than individuals with obesity and type 2
diabetes. A recent study evaluated the association between facal
A. muciniphila abundance, facal microbiome gene richness, diet,
host characteristics, and their changes after calorie restriction
(CR) (Dao et al., 2016). While CR is not always easy to achieve,
several small-molecule targets have emerged in the impetuous
search for calorie restriction mimetics, of which resveratrol,
metformin, and rapamycin are the most extensively studied.
Interaction of dietary phytochemicals as resveratrol through
the pattern recognition receptors (TRLs, NLRs) with intestinal
microbiota are thoroughly described by Ferguson et al. (2016).
Bioavailability of dietary phytochemicals is of critical importance
if a pharmaceutical approach is applied, and the determination
is not only complicated by the biochemical properties of the
molecule but also by microbial-mediated metabolism. Humans
absorb resveratrol well, but since it is quickly metabolized and
eliminated, its’ bioavailability is low. Recent findings showed that
resveratrol reduces levels of trimethylamine-N-oxide (TMAO),
known to be a contributory factor in the development of
atherosclerosis (Chen et al., 2016). This was partially mediated
through down-regulating the enterohepatic farnesoid X receptor-
fibroblast growth factor (FXR) axis, and indicates that gut
microbiotamay become an interesting target for pharmacological
and nutritional precision medicine interventions to decrease the
risk of developing metabolic diseases.
In summary, The Human Gutome concept gives researchers,
nutritionists, and clinicians a common platform for
interdisciplinary data sharing in the evolving microbiome
science.
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